Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11-20190----1件: 93 💬
211C-csar----2件: 93, 94 💬
313-15MG/KG/D ursodeoxycholic----1件: 93 💬
418-22MG/KG/D ursodeoxycholic----1件: 93 💬
52MG CS0159----1件: 93 💬
63 MG [14C]-A4250 capsule----3件: 93, 297, 338 💬
73-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-YL]methyl}amino)pentanedioic acid----1件: 93 💬
83A,7A-dihydroxy-6A-ethyl-5ßcholan-24-OIC acid----1件: 93 💬
96 alpha-ethylchenodeoxycholic acid (6-edca), OCA, INT-747----1件: 93 💬
106-ecdca1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
116?-ethylchenodeoxycholic acid (6-ecdca), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
126A-ethylchenodeoxycholic acid (6-ecdca), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
136A-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
146A-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3A,7A-dihydroxy-6A-ethyl-5ßcholan-24-O1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
156A-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
166A-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3A,7A-dihydroxy-6A-ethyl-5ßcholan-24-O1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
17A11ha02----1件: 93 💬
18A4250----4件: 93, 296, 297, 338 💬
19Abatacept1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬26件: 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
20Acido obeticolico----3件: 93, 94, 296 💬
21Acido ursodessicolico----1件: 93 💬
22Alkaline phosphatase1件: Alkaline Phosphatase---3件: 46, 93, 97 💬
23Alpha-ethylchenodeoxycholic acid (6-edca), OCA, INT-747----1件: 93 💬
24APD334----5件: 93, 96, 97, 98, 269 💬
25ASC42 10 MG----1件: 93 💬
26ASC42 15 MG----1件: 93 💬
27ASC42 5 MG----1件: 93 💬
28Atorvastatin1件: Atorvastatin2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬17件: 13, 22, 46, 49, 51, 58, 79, 84, 88, 93, 96, 97, 160, 225, 271, 297, 299 💬
29Babaodan capsule----1件: 93 💬
30Baricitinib1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬19件: 2, 13, 41, 46, 49, 50, 51, 53, 54, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
31BCD-085----2件: 93, 271 💬
32Bezafibrat genericon retard 400 MG----1件: 93 💬
33Bezafibrate1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬8件: 20, 93, 94, 160, 296, 316, 324, 344 💬
34Bezafibrate 100 MG1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
35Bezafibrate 200 MG1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
36Bezafibrate 200 MG IN addition TO udca therapy2件: Bezafibrate,
Ursodeoxycholic acid		2件: Ursodiol ,
Bezafibrate 💬 		2件: NR1C1,
NR1H4 💬 		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
37Bezafibrate 200 MG oral tablet1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
38Bezafibrate 400 MG1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
39Bezafibrate 400 MG IN addition TO udca therapy2件: Bezafibrate,
Ursodeoxycholic acid		2件: Ursodiol ,
Bezafibrate 💬 		2件: NR1C1,
NR1H4 💬 		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
40Bezafibrate IR1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
41Bezafibrate SR1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
42Bezafibrate, beza, BZF, bezalip1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
43Bezafibrate, beza, BZF, bezalip mono1件: Bezafibrate1件: Bezafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
44Bezafilbrate IR----1件: 93 💬
45Bezalip----2件: 93, 94 💬
46Biological: mesenchymal stem cell----1件: 93 💬
47Budesonide1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬7件: 66, 93, 94, 95, 96, 97, 98 💬
48Calcium2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬 		--12件: 6, 46, 49, 68, 93, 95, 97, 156, 222, 235, 271, 274 💬
49Cilofexor1件: Cilofexor---2件: 93, 94 💬
50CNP-104----1件: 93 💬
51CNTO1275----6件: 46, 49, 84, 93, 96, 97 💬
52Colchicine1件: Colchicine1件: Colchicine 💬 9件: TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB,
TUBB 💬 		11件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬8件: 42, 46, 50, 56, 93, 97, 210, 266 💬
53Combination antiviral therapy----1件: 93 💬
54CR845 1.0 MG----1件: 93 💬
55CS0159----2件: 93, 94 💬
56Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
57Cyclosporin A1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3C,
PPP3C,
PPP3C,
PPP3R,
PPP3R 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬11件: 46, 49, 53, 54, 56, 60, 62, 93, 95, 113, 164 💬
58Denosumab1件: Denosumab1件: Denosumab 💬 1件: TNFSF11 💬 8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬10件: 46, 50, 70, 75, 77, 93, 95, 96, 274, 299 💬
59E6011----4件: 46, 93, 96, 97 💬
60EDP-305----1件: 93 💬
61EDP-305 dose 1----1件: 93 💬
62EDP-305 dose 2----1件: 93 💬
63Elafibranor1件: Elafibranor1件: Elafibranor 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 93, 94 💬
64Elafibranor 120 MG1件: Elafibranor1件: Elafibranor 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 93, 94 💬
65Elafibranor 80 MG1件: Elafibranor1件: Elafibranor 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 93, 94 💬
66Elafibranor 80MG1件: Elafibranor1件: Elafibranor 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
67Emtricitabine1件: Emtricitabine1件: Emtricitabine 💬 --3件: 13, 93, 325 💬
68EP547----2件: 93, 94 💬
69EP547 tablet 25MG----2件: 93, 94 💬
70EP547 tablet 75MG----2件: 93, 94 💬
71Ezetimibe1件: Ezetimibe1件: Ezetimibe 💬 1件: NPC1L1 💬 1件: Fat digestion and absorption 💬4件: 79, 93, 149, 260 💬
72Ezetrol1件: Ezetimibe1件: Ezetimibe 💬 1件: NPC1L1 💬 1件: Fat digestion and absorption 💬2件: 93, 260 💬
73EZT----1件: 93 💬
74Fecal microbiota1件: Fecal microbiota---5件: 13, 49, 93, 96, 97 💬
75Fenofibrate1件: Fenofibrate1件: Fenofibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬6件: 8, 79, 93, 94, 97, 265 💬
76Fenofibrate 200MG1件: Fenofibrate1件: Fenofibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
77Fenofibrate combined with ursodeoxycholic acid2件: Fenofibrate,
Ursodeoxycholic acid		2件: Fenofibrate ,
Ursodiol 💬 		2件: NR1C1,
NR1H4 💬 		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
78Fenofibrate IN combination with ursodeoxycholic acid1件: Fenofibrate1件: Fenofibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
79FFP104----2件: 93, 96 💬
80Fully human monoclonal antibody directed against CXCL10----1件: 93 💬
81Fuzhenghuayu----1件: 93 💬
82Genetic analysis----7件: 34, 85, 90, 93, 94, 96, 234 💬
83GFT505----2件: 93, 94 💬
84GKT137831----2件: 85, 93 💬
85Golexanolone1件: Golexanolone---1件: 93 💬
86GR3027----1件: 93 💬
87GS-9674----2件: 93, 94 💬
88GS-9674 100 MG----1件: 93 💬
89GS-9674 30 MG----1件: 93 💬
90GSK2330672----1件: 93 💬
91GSK2330672/linerixibat 40 MG1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
92GYPP-06 (GKT137831 free base), C10071301-D----1件: 93 💬
93Hesperidin1件: Hesperidin1件: Hesperidin 💬 --1件: 93 💬
94High protein high fiber diet----2件: 93, 95 💬
95ICG----3件: 93, 94, 235 💬
96INT-747----1件: 93 💬
97INT-747, OCA----2件: 93, 94 💬
98IPN60190----2件: 93, 94 💬
99K-808----1件: 93 💬
100Linerixibat1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
101Linerixibat (GSK2330672) 40 MG1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
102Linerixibat (GSK2330672) 45 MG1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
103Linerixibat (GSK2330672) 45MG1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
104LJN452----1件: 93 💬
105LJN452, 0,01 MG----1件: 93 💬
106LJN452, 0,03 MG----1件: 93 💬
107LJN452, 0,1 MG----1件: 93 💬
108LUM001----5件: 93, 94, 296, 297, 338 💬
109LY3009104----10件: 46, 49, 50, 93, 107, 135, 265, 268, 325, 345 💬
110MBX 8025----1件: 93 💬
111MBX-8025----3件: 79, 93, 94 💬
112MBX-8025, dsic----1件: 93 💬
113MBX-8025, formulation 2----1件: 93 💬
114Methotrexate1件: Methotrexate2件: Methotrexate ,
Methotrexate sodium 💬 		2件: DHFR,
DHFR 💬 		3件: Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬37件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
115Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬45件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
116Methylprednisolone and azathioprine1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 93, 95 💬
117Methylprednisolone and mycophenolate mofetil1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 93, 95 💬
118Minodronic acid1件: Minodronic acid---4件: 6, 46, 93, 95 💬
119Modafinil1件: Modafinil1件: Modafinil 💬 --4件: 6, 13, 49, 93 💬
120Moexipril1件: Moexipril2件: Moexipril hydrochloride ,
Moexipril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 93 💬
121Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH,
IMPDH 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬32件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
122Nalmefene1件: Nalmefene3件: Nalmefene hydrochloride ,
Nalmefene ,
Nalmefene hydrochloride hydrate 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 6, 93 💬
123NCA 500MG----1件: 93 💬
124NGM282----2件: 93, 94 💬
125NI-0801----1件: 93 💬
126Norucholic acid (NCA) 500 MG1件: norUrsodeoxycholic acid---1件: 93 💬
127Obeticholic acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬3件: 93, 265, 296 💬
128Obeticholic acid 10 MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
129Obeticholic acid 5 MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
130Obeticholic acid tablets1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
131OCA----3件: 93, 94, 296 💬
132Ocaliva1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬2件: 93, 296 💬
133Ocaliva 10MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
134Ocaliva 5MG1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
135Olumiant1件: Baricitinib1件: Baricitinib 💬 2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬9件: 46, 49, 93, 107, 135, 265, 268, 325, 345 💬
136Part 1: LJN452----1件: 93 💬
137Part 2: LJN452 dose level 1----1件: 93 💬
138Part 2: LJN452 dose level 2----1件: 93 💬
139Pemafibrate1件: Pemafibrate1件: Pemafibrate 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
140Pentoxifylline1件: Pentoxifylline1件: Pentoxifylline 💬 --11件: 26, 56, 84, 93, 96, 97, 113, 220, 222, 296, 298 💬
141Phenylbutyrate1件: Phenylbutyric acid1件: Sodium phenylbutyrate 💬 --7件: 2, 93, 94, 244, 251, 297, 338 💬
142Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬54件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
143Probiotic1件: Lactobacillus acidophilus1件: Lactomin 💬 --9件: 2, 6, 93, 96, 97, 127, 193, 266, 299 💬
144PVT201----1件: 93 💬
145Pyridoxine 10MG BP1件: Pyridoxine2件: Pyridoxine hydrochloride ,
Pyridoxine 💬 		--1件: 93 💬
146Questran1件: Cholestyramine1件: Cholestyramine resin 💬 --4件: 93, 254, 297, 338 💬
147Raltegravir1件: Raltegravir2件: Raltegravir ,
Raltegravir potassium 💬 		--4件: 13, 26, 93, 265 💬
148Rhudex 100 MG (127 MG rhudex choline salt) granules----1件: 93 💬
149Rhudex 25 MG (31.75 MG rhudex choline salt) granules----1件: 93 💬
150Rhudex 50 MG (63.5 MG rhudex choline salt) granules----1件: 93 💬
151Rifampicin1件: Rifampin2件: Rifampin ,
Rifampicin sodium 💬 		--8件: 6, 13, 17, 46, 93, 97, 299, 338 💬
152Rifaximin1件: Rifaximin1件: Rifaximin 💬 --8件: 6, 65, 93, 96, 97, 99, 296, 299 💬
153Risedronic acid1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬3件: 93, 95, 274 💬
154Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
155S-adenosyl-L-methionine----1件: 93 💬
156S-adenosyl-methionine (same) capsules----1件: 93 💬
157Saroglitazar magnesium 1 MG1件: Saroglitazar2件: Saroglitazar ,
Saroglitazar magnesium 💬 		3件: NR1C1,
NR1C2,
NR1C3 💬 		22件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬1件: 93 💬
158Saroglitazar magnesium 2 MG1件: Saroglitazar2件: Saroglitazar ,
Saroglitazar magnesium 💬 		3件: NR1C1,
NR1C2,
NR1C3 💬 		22件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬1件: 93 💬
159Saroglitazar magnesium 4 MG1件: Saroglitazar2件: Saroglitazar ,
Saroglitazar magnesium 💬 		3件: NR1C1,
NR1C2,
NR1C3 💬 		22件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬1件: 93 💬
160Seladelpar1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬2件: 93, 94 💬
161Seladelpar / MBX-8025 200 MG1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
162Seladelpar / MBX-8025 50 MG1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
163Seladelpar 10 MG1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
164Seladelpar 10 MG capsule1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
165Seladelpar 10 MG or less1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
166Seladelpar 5 MG1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
167Seladelpar 5 MG capsule1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
168Seladelpar 5-10 MG1件: Seladelpar2件: Seladelpar ,
Seladelpar lysine 💬 		1件: NR1C3 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93 💬
169Setanaxib1件: Setanaxib---2件: 93, 218 💬
170Sortis 10 MG----1件: 93 💬
171Standard OF care: udca----1件: 93 💬
172Sublimated mare milk----1件: 93 💬
173T cell injection targeting CD19 chimeric antigen receptor----6件: 46, 49, 51, 53, 93, 300 💬
174Tauroursodeoxycholic acid capsules1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬 --1件: 93 💬
175TDF/FTC/LPV/R----1件: 93 💬
176Tenofovir disoproxil2件: Tenofovir,
Tenofovir disoproxil		4件: Tenofovir disoproxil fumarate ,
Tenofovir ,
Tenofovir disoproxil phosphate ,
Tenofovir disoproxil maleate 💬 		--1件: 93 💬
177Tetrathiomolybdate1件: Tetrathiomolybdate---3件: 85, 93, 171 💬
178Thiamine1件: Thiamine3件: Thiamine hydrochloride ,
Thiamine mononitrate ,
Thiamine 💬 		--3件: 13, 93, 265 💬
179Tiamin DAK----2件: 93, 97 💬
180Tiamin SAD----2件: 93, 97 💬
181Tigecycline1件: Tigecycline1件: Tigecycline 💬 --1件: 93 💬
182TQA3526----1件: 93 💬
183Tropifexor1件: Tropifexor1件: Tropifexor 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
184Udca1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬5件: 67, 93, 94, 97, 296 💬
185Umbilical cord derived mesenchymal stem cell (UC -MSC) transplantation----2件: 93, 296 💬
186Ursodeoxycholic acid1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬8件: 6, 67, 84, 93, 94, 95, 96, 97 💬
187Ursodeoxycholic acid 300MG capsule1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
188Ursodeoxycholic acid 300MG tablet1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
189Ursodeoxycholic acid capsules1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
190Ursodeoxycholic acid combination OF immunosuppressive agents1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬2件: 93, 95 💬
191Ursodeoxycholic acid combined with total glucosides OF paeony1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
192Ursodeoxycholic acid only1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
193UrsodeoxycholsäURE----1件: 93 💬
194Ursodiol1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬6件: 8, 20, 93, 97, 234, 299 💬
195Ursofalk1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬4件: 93, 94, 96, 97 💬
196Ursofalk® 500 MG FILM-coated tablets1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
197Ursofalk® 500 MG filmtabletten1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
198Ursofalk® capsules1件: Ursodeoxycholic acid1件: Ursodiol 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
199Ustekinumab1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬16件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
200Ustekinumab 180 MG1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 93 💬
201Ustekinumab 45 MG1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬1件: 93 💬
202Ustekinumab 90 MG1件: Ustekinumab1件: Ustekinumab 💬 3件: IL12A,
IL12B,
IL23A 💬 		28件: African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬5件: 49, 50, 93, 96, 97 💬
203Vitamin D1件: Vitamin D---20件: 6, 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 299 💬
204Volixibat1件: Volixibat2件: Volixibat potassium ,
Volixibat 💬 		--2件: 93, 94 💬
205Volixibat potassium1件: Volixibat2件: Volixibat potassium ,
Volixibat 💬 		--2件: 93, 94 💬
206Zoledronic acid1件: Zoledronic acid5件: Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬13件: 6, 13, 46, 75, 77, 93, 95, 96, 97, 270, 274, 299, 333 💬